Phathom Pharmaceuticals
PHAT
PHAT
58 hedge funds and large institutions have $794M invested in Phathom Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 24 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
54% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 24
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
58
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$1.59M | |
| 2 | +$1.57M | |
| 3 | +$598K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$427K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$332K |
Top Sellers
| 1 | -$5.51M | |
| 2 | -$1.35M | |
| 3 | -$1.04M | |
| 4 |
B
BP
London,
United Kingdom
|
-$753K |
| 5 |
Rockefeller Capital Management
New York
|
-$572K |